首页|基于两样本双向孟德尔随机化联合FDA不良事件报告系统数据库分析阿片类药物与胆结石的关联

基于两样本双向孟德尔随机化联合FDA不良事件报告系统数据库分析阿片类药物与胆结石的关联

扫码查看
目的 分析阿片类药物与胆结石的关联,为临床胆结石患者合理使用阿片类药物提供参考。方法 采用两样本双向孟德尔随机化(MR)分析,从基因层面预测阿片类药物的使用与胆结石的关联,并利用FDA不良事件报告系统(FAERS)数据库中记录的真实世界药物不良反应数据加以验证。结果 基因预测显示,阿片类药物的使用与胆结石发生风险相关,正向MR分析逆方差加权法结果为OR=1。12,95%CI:1。02~1。24,P<0。05,β=0。114,且结果不存在反向关联干扰。FAERS数据库证实,阿片类药物与胆结石发生风险有关,但并非所有阿片类药物均与胆结石发生风险有关,其中阿片μ受体完全性激动剂与胆结石发生风险有关,而阿片μ受体部分激动剂和阿片受体混合激动-拮抗剂与胆结石发生风险无关。结论 阿片类药物发生胆结石的风险可能与药理作用机制相关。胆结石患者如确需使用阿片类药物应使用μ1受体高选择性激动剂、μ受体部分激动剂和阿片受体混合激动-拮抗剂,避免使用μ受体完全性激动剂中低选择性的品种。
The association between opioid drugs and gallstones based on two-sample bidirectional Mendelian randomization and the FDA adverse event reporting system database
Objective To analyze the association between opioid drugs and gallstones,provide reference for the rational use of opioid drugs in gallstone patients.Methods Two-sample bidirectional Mendelian randomization(MR)analysis was used to predict the association between opioid drugs and gallstones at the genetic level,validated it using real-world adverse drug reaction data recorded in the FDA adverse event reporting system(FAERS)database.Results Genetic prediction showed that the use of opioid drugs was associated with gallstones.The inverse variance weighted results of forward MR analysis were OR=1.12,95%CI:1.02 to 1.24,P<0.05,β=0.114,and there was no inverse association interference in the results.FAERS database confirms that opioid drugs are associated with gallstones,but not all opioid drugs are associated with gallstones.Complete agonists of μ receptors are associated with gallstones,while partial agonists of μ receptors and mixed agonists antagonists of opioid receptors have no risk of gallstones.Conclusion The risk of gallstones with opioid drugs may be related to pharmacological mechanisms of action.Patients with gallstones should use μ1 receptor high selective agonists,μ receptor partial agonists,and opioid receptor mixed agonists antagonists and avoid the use of low selective varieties of μ receptor complete agonists.

Mendelian randomizationFDA adverse event reporting systemopioid drugsgallstonecausal correlation

尹航、张美娟、刘骏、吴小芳、董瑞华

展开 >

首都医科大学附属北京友谊医院 研究型病房,北京 100050

孟德尔随机化 FDA不良事件报告系统 阿片类药物 胆结石 因果关联

2024

临床药物治疗杂志
北京药学会

临床药物治疗杂志

CSTPCD
影响因子:1.07
ISSN:1672-3384
年,卷(期):2024.22(10)